Dr. Martens (LON:DOCS – Get Free Report) released its quarterly earnings results on Thursday. The company reported GBX 2.40 ($0.03) earnings per share for the quarter, Digital Look Earnings reports. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%.
Dr. Martens Stock Performance
LON DOCS opened at GBX 80.15 ($1.09) on Friday. Dr. Martens has a fifty-two week low of GBX 43.02 ($0.58) and a fifty-two week high of GBX 88 ($1.20). The stock has a market cap of £778.07 million, a price-to-earnings ratio of 11.36, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The business has a fifty day moving average of GBX 54.73 and a 200-day moving average of GBX 62.64. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s dividend payout ratio (DPR) is 42.53%.
Insider Transactions at Dr. Martens
Analyst Ratings Changes
Separately, Royal Bank of Canada cut their price target on Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a “sector perform” rating for the company in a report on Monday, May 19th.
Check Out Our Latest Stock Report on DOCS
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Further Reading
- Five stocks we like better than Dr. Martens
- Best Energy Stocks – Energy Stocks to Buy Now
- Is Meta Plotting a Stablecoin Comeback Years After Libra’s Flop?
- Industrial Products Stocks Investing
- Silver’s Options Sizzle: Are Traders Betting on a Breakout?
- Basic Materials Stocks Investing
- AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.